Skip to content

Advertisement

Volume 10 Supplement 1

de Senectute: Age and Health Forum

  • Meeting abstract
  • Open Access

Cutaneus cancers in elderly Medical treatment of actinic keratosis and superficial coutaneus cancers: imiquimod

  • 1
BMC Geriatrics201010 (Suppl 1) :A92

https://doi.org/10.1186/1471-2318-10-S1-A92

  • Published:

Keywords

  • Public Health
  • Carcinoma
  • Adverse Event
  • Cell Carcinoma
  • Medical Treatment

Background

The aim of this work is to evaluate the efficacy and safety of imiquimod 5% cream used in the treatment of certain non-melanoma skin cancers.

Materials and methods

We treated 30 subjects: 5 actinic keratosis, 3 cheratoacanthomas, 5 cutaneous horns, 5 superficial basal cell carcinomas, 12 nodular basal cell carcinomas according to the therapeutic pattern - five applications a week for 6-12 weeks -. The patients with nodular forms could not be treated with surgery for severe chronic deseases, age, or refusal.

Results

Imiquimod 5% cream was effective and well tolerated both in actinic keratosis and in superficial and nodular basal cell carcinoma.

Conclusions

The treatment of certain non-melanoma coutaneous toumors with imiquimod 5% cream, has been effective, without collateral effects; erythema, edema, vesicles, crusts and erosions with itching or burning in the application area, have been the most frequent adverse events which however did not cause the suspension of therapy.

A diligent and continuative follow-up is necessary.

Authors’ Affiliations

(1)
ASP Cosenza, Corigliano Calabro, Italy

Copyright

© Dastoli; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd.

Advertisement